Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Report
  • Published:

Successful allogeneic bone marrow transplantation from an HBV-positive donor into an HBV-positive recipient using lamivudine

Abstract

A 21-year-old woman with severe aplastic anemia underwent allogeneic bone marrow transplantation from an HLA-identical sibling donor. The patient also had chronic hepatitis B and the donor was an HBV carrier. To decrease HBV and improve hepatic dysfunction before BMT, the patient had received lamivudine for 6 months. After marrow transfusion, administration of lamivudine was continued to inhibit replication of donor-derived HBV. The patient showed hematological engraftment on day 13 without any serious liver dysfunction. Eight months after BMT, she is now alive and well without chronic liver GVHD or reactivation of hepatitis B. HBV-DNA was not detected in the patient's serum. Administration of lamivudine to a BMT recipient with chronic hepatitis B may be a safe and promising way to prevent fatal liver dysfunction in the setting of allogeneic BMT, even in the event of BMT from an HBV-positive donor.

Bone Marrow Transplantation (2002) 29, 269–271. doi:10.1038/sj.bmt.1703350

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Ustun C, Koc H, Karayalcin S et al. Hepatitis B virus infection in allogeneic bone marrow transplantation Bone Marrow Transplant 1997 20: 289 296

    Article  CAS  Google Scholar 

  2. Mertens T, Kock J, Hampl W et al. Reactivated fulminant hepatitis B virus replication after bone marrow transplantation: clinical course and possible treatment with ganciclovir J Hepatol 1995 25: 968 971

    Article  Google Scholar 

  3. Lau GKK, Liang R, Chiu EKW et al. Hepatic events after bone marrow transplantation in patients with hepatitis B infection: a case controlled study Bone Marrow Transplant 1997 19: 795 799

    Article  CAS  Google Scholar 

  4. Locasciulli A, Alberti A, Bandini G et al. Allogeneic bone marrow transplantation from HBsAg+ donors: a multicenter study from the Gruppo Italiano Trapiano di Midolo Osseo (GITMO) Blood 1995 86: 3236 3240

    CAS  PubMed  Google Scholar 

  5. Lai C-L, Chien R-N, Leung NWY et al. A one-year treatment of lamivudine for chronic hepatitis B New Engl J Med 1998 339: 61 68

    Article  CAS  Google Scholar 

  6. Dienstag JL, Schiff ER, Wright TL et al. Lamivudine as initial treatment for chronic hepatitis B in the United States New Engl J Med 1998 341: 1256 1263

    Article  Google Scholar 

  7. Picardi M, Selleri C, DeRosa G et al. Lamivudine treatment for chronic replicative hepatitis B virus infection after allogeneic bone marrow transplantation Bone Marrow Transplant 1998 21: 1267 1269

    Article  CAS  Google Scholar 

  8. Al-Taie OH, Mork H, Gassel AM et al. Prevention of hepatitis B flare-up during chemotherapy using lamivudine: case report and review of the literature Ann Hematol 1999 78: 247 249

    Article  CAS  Google Scholar 

  9. Nevens F, Main J, Honkoop P et al. Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study Gastroenterol 1997 113: 1258 1263

    Article  CAS  Google Scholar 

  10. Dienstag LJ, Perrillo RP, Schiff ER et al. A preliminary trial of lamivudine for chronic hepatitis B infection New Engl J Med 1995 333: 1657 1661

    Article  CAS  Google Scholar 

  11. Uchida N, Gondo H, Himeji D et al. Lamivudine therapy for a hepatitis B surface antigen (HBsAg)-positive leukemia patient receiving myeloablative chemotherapy and autologous stem cell transplantation Bone Marrow Transplant 2000 26: 1243 1245

    Article  CAS  Google Scholar 

  12. Reshef R, Sbeit W, Tur-Kaspa R . Lamivudine in the treatment of acute hepatitis B New Engl J Med 2000 343: 1123 1124

    Article  CAS  Google Scholar 

  13. Liaw YF, Chien RN, Yeh CT et al. Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy Hepatology 1999 30: 567 572

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hashino, S., Takahata, M., Nozawa, A. et al. Successful allogeneic bone marrow transplantation from an HBV-positive donor into an HBV-positive recipient using lamivudine. Bone Marrow Transplant 29, 269–271 (2002). https://doi.org/10.1038/sj.bmt.1703350

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703350

Keywords

This article is cited by

Search

Quick links